Mitochondrial fatty acid synthesis (mtFAS) is an underappreciated but highly conserved metabolic process, indispensable for mitochondrial respiration. It was recently reported that dysfunction of mtFAS causes childhood onset of dystonia and optic atrophy in humans (MEPAN). To study the role of mtFAS in mammals, we generated three different mouse lines with modifications of the Mecr gene, encoding mitochondrial enoyl-CoA/ACP reductase (Mecr). A knock-out-first type mutation, relying on insertion of a strong transcriptional terminator between the first two exons of Mecr, displayed embryonic lethality over a broad window of time and due to a variety of causes. Complete removal of exon 2 or replacing endogenous Mecr by its functional prokaryotic analogue fabI (Mecr tm(fabI) ) led to more consistent lethality phenotypes and revealed a hypoplastic placenta. Analyses of several mitochondrial parameters indicate that mitochondrial capacity for aerobic metabolism is reduced upon disrupting mtFAS function. Further analysis of the synthetic Mecr tm(fabI) models disclosed defects in development of placental trophoblasts consistent with disturbed peroxisome proliferator-activated receptor signalling. We conclude that disrupted mtFAS leads to deficiency in mitochondrial respiration, which lies at the root of the observed pantropic effects on embryonic and placental development in these mouse models.
Introduction
Fatty acid synthesis (FAS) in mammalian cells takes place in two compartments; in the cytosol where it follows the canonical integrated pathway (FAS I) and in mitochondria (mtFAS).
The mtFAS pathway resembles bacterial type II FAS where each step is carried out by separate enzymes (1) . Currently, the only mtFAS product with a confirmed physiological function is octanoic acid, which is used in endogenous lipoic acid (LA) synthesis. LA acts as a cofactor of enzymes of oxidative decarboxylation reactions like pyruvate dehydrogenase (PDH), a-ketoglutarate dehydrogenase (KGD) as well as two dehydrogenases in amino acid metabolism, the glycine cleavage system and branched chain dehydrogenase (2) . Studies in Saccharomyces cerevisiae indicate that inactivation of any enzyme in the mtFAS pathway leads to respiratory defects, lack of cytochromes due to disturbed mitochondrial translation and respiratory complex assembly, rudimentary mitochondria and complete loss of protein lipoylation in yeast (3) (4) (5) (6) . In mouse models, adult mice subjected to tamoxifen-induced inactivation of the Mcat gene, encoding malonyl-CoA transferase in mtFAS, suffered from loss of lipoylation, premature aging symptoms and disturbed energy metabolism (7) .
The 2-enoyl-thioester reductase (ETR) catalyzes the NADPHdependent reduction of enoyl-ACP (acyl carrier protein) to saturated acyl-ACP in the mtFAS pathway. The disruption of the ETR1 gene encoding this reductase in yeast leads to the typical mtFAS defect phenotype described earlier, while overexpression of ETR1 results in dramatically enlarged mitochondria (3) . The mitochondrial enoyl-CoA/ACP reductase (Mecr) is the mammalian orthologue of ETR and is highly conserved in higher eukaryotes (8) . The overexpression of Mecr in mouse resulted in cardiac myopathy, as well as mitochondrial enlargement in this organ (9) similar to the phenotype observed in yeast. Recently, the first human individuals suffering from a disorder caused by recessive mutations in the MECR gene have been described. These patients display childhood onset dystonia, optic atrophy and basal ganglia signal abnormalities on MRI together with decreased MECR function and mitochondrial protein lipoylation (10) . Due to the defects observed in the nervous system of the patients, the term MEPAN (mitochondrial enoyl-CoA reductase protein-associated neurodegeneration) was proposed as name for the disorder.
Etr1, Mecr/MECR and other eukaryotic homologs belong to the family of medium-chain dehydrogenase/reductase proteins whereas most prokaryotic functional analogues, like fabI, are of the short-chain dehydrogenase/reductase type (1). Expression of MECR or mitochondrially targeted bacterial fabI in the yeast etr1D mutant alleviated the respiratory defect of these cells, indicating that it is the enoyl reductase activity which is required for growth (3, 8) . A role of Mecr in transcriptional regulation mediated by peroxisome proliferator-activated receptors (PPAR) has recently been proposed independently by two different groups (11, 12) although it is controversial whether this effect is due to a product of mtFAS or direct action of Mecr as a transcriptional co-activator.
In the study presented here, we demonstrate that Mecr inactivation in mice leads to embryonic lethality. We report the results of our studies of the time points and causes of embryonic lethality in three different Mecr models: embryos produced by a leaky 'knock-out-first' mouse line, a complete knock-out line generated by removal of a critical exon, and synthetic hypomorphic embryos carrying a replacement of mammalian Mecr with the bacterial fabI analogue. This is the first report on the roles of Mecr or mtFAS in mouse embryonic development.
Results
Generation of 'knock-out-first' type (Mecr tm1a ) and Mecr 
Generation of Mecr tm(fabI) mice
As mitochondrially targeted bacterial fabI complements respiratory growth of etr1 deficient yeast cells and can be selectively inhibited by the drug triclosan (3,6), we sought to test whether an analogous construct would rescue the Mecr deficiency in mice. Therefore, a sequence encoding the bacterial fabI ETR was introduced into exon 2 of mouse Mecr. The construct was C-terminally tagged with a double HA epitope allowing visualization of fabI expression using western blot analysis. The splicing acceptor sites of exon 2 of Mecr as well as 54 nucleotides of the exon 2 itself were maintained in frame with the fabI coding region. As the Mecr mitochondrial targeting sequence (MTS) is encoded by exon 1, splicing between the latter and the modified exon 2 is predicted to yield in a chimeric mRNA encoding HA-tagged fabI N-terminally extended with the Mecr MTS. This construct is followed by the strong transcriptional terminator, BGH (13) and was designed to exclude the possibility of producing intact Mecr (Fig. 1C) Fig. S3B ).
Mecr and fabI in the Mecr mutant mouse lines
Production of the fabI transcript in E 9.5 embryos of homozygous mutants, heterozygous and wild type embryos from heterozygous Mecr tm(fabI) females was studied by RT-PCR. We robustly detected the fabI transcript in homozygous knock-in embryos. In comparison, the fabI mRNA levels were about 25% in heterozygous embryo and fabI transcription was essentially absent in wild type embryos ( Fig. 2A) . In addition, Mecr mRNA expression in all the embryos derived from pregnant heterozygous Mecr tm(fabI)
, Mecr tm1a and Mecr tm1d were analyzed by RT-PCR and found reduced to background levels in all the homozygous mutants compared with heterozygous or wild type controls (Supplementary Material, Fig. S4 ). Embryos of identical genotype were pooled to obtain cell extract material sufficient for immunoblot analysis. The expression of fabI in these extracts was analyzed by western blotting probing for the C terminal HA tag to confirm presence of the chimeric protein in Mecr tm(fabI) embryos. A strong signal was observed when probing extract of homozygous fabI knock-in embryos with the HA antibody, a less intense signal was observed in extracts from heterozygous embryos. A weak signal corresponding to a protein of similar molecular mass was also observed in samples from homozygous wild type (Fig. 2B) . However, the signals from samples containing the fabI construct were consistently and reproducibly much stronger in repeated experiments. Therefore, we suggest that the band observed in wild type embryo extract is a signal from an unspecific interaction with a protein of similar size as fabI-HA. An identical signal could be seen from extracts prepared from wild type embryos developing in Mecr þ/þ mothers (data not shown), indicating that the cross-reacting band is not a result of contamination with maternal tissue expressing fabI-HA. ). This sequence is followed by transcription terminator BGH attached to an FRT-flanked selection cassette. The figure is not drawn to scale. Results are shown as means 6 SD, n ¼ 5 per group, independent samples t test, ***P < 0.001, **P < 0.01, *P < 0. lines did not produce any homozygous mutant pups, indicating that the mutant embryos died during embryonic development and that fabI complementation did not rescue the embryonic lethality phenotype. Therefore, triclosan inhibition of fabI activity for induction of a phenotype as initially planned was unnecessary and the analysis of the breedings was extended to embryonic lethality studies of all three mutant lines. When pregnant heterozygous Mecr tm1a females were dissected between E 7.5 and E 18.5 ( Fig. 1D , Supplementary Material, Table S1 and Supplementary Material, Fig. S1 ), we found that homozygous knock-out embryos were smaller in size, displayed opaque yolk sac membranes and were adherent to membranes by E 8.5, whereas wild type yolk sac membranes were translucent and clear and embryos were easy to separate from membranes. Follow-up dissections indicated that the time of embryonic death was variable, occurring between E 9.5 and E 15.5 as determined by visible heart beats or pulsing blood in umbilical vessel and necrotic signs. Long-surviving homozygous knock-out embryos of the Mecr tm1a line found alive at E 14.5 were pale and had hemorrhages (Fig. 3A) . Due to the variability in embryonic lethality, we suspected that Mecr tm1a con- embryos were dead (based on absence of heart beat) and at varying stages of resorption at E 11.5. Dissections focusing on the period E 7.5-E 12.5 ( Fig. 1D , Supplementary Material, Table  S2 and Supplementary Material, Fig. S1 ) confirmed the time window of embryonic death ranged from E 9.5 to E 11.5. The homozygous 1d knock-out embryos displayed abnormal morphology similar to 1a knock-out embryos at E 8.5. At E 9.5, some of homozygous mutants were dead. The live homozygous Mecr tm1d mutant embryos were smaller in size and displayed a developmental delay characterized by retention of dorsal curvature, resembling the morphology of wild type E 8.5 embryos and adherent fetal membranes (Fig. 3B) . The live 1d knock-out embryos at E 10.5 were also paler than control littermates (Fig. 3C) . Dissections of pregnant females at specific time point of gestation varying from E 8.5 to E 13.5 were also carried out for Mecr tm(fabI) mice (Fig. 1D , Supplementary Material, Table S2 and Supplementary Material, Fig. S1 ). The homozygous knock-in embryos were found to develop normally and undistinguishable from wild type and heterozygous littermates until E 8.5. At E 10.5, all the homozygous knock-in embryos were paler, fragile and smaller than their heterozygous or wild type littermates ( Fig. 3D) , with pale and empty yolk sac vessels ( Fig. 3E ) and their heart beats were weak or absent. All the homozygous Mecr tm(fabI)
embryos were dead and at varying stages of resorption at E 11.5, establishing a period of embryonic lethality in knock-in mice from E 10.5 to E 11.5. Chi square test analysis of embryos at E 8.5 indicated that the numbers of genotypes in each of generated modified mouse lines were not significantly different from expected Mendelian segregation. These results show that there was no genotype specific death among the experimental lines before E 8.5. Despite numerous efforts, we were unable to produce mouse embryonic fibroblasts from either the homozygous Mecr tm1a or fabI knock-in embryos.
Protein lipoylation
Total protein extracts from all the Mecr knock-out and fabI gene replacement embryos (either E 11.5 or E 9.5) were probed with LA antibody. Presence of lipoylated proteins was used as indicator for functionality of the mtFAS pathway (5). The lipoylated E2 subunits of PDH (Dlat) and KGD (Dlst)) were present in extracts from all wild type samples as well as in corresponding heterozygotes (Fig. 4A ). Interestingly, a clear lipoylated Dlat signal was observed in protein extracts from homozygous Mecr tm1a embryos at E 11.5 ( Fig. 4A ). The observation is in line with the proposed leakiness of the Mecr tm1a construct in homozygous embryos, allowing for synthesis of low levels of LA used for modification of Dlat. The result also agrees with the observations of the embryonic lethality studies (Supplementary Material, Table S1 and 
Mitochondrial respiratory chain activities in Mecr tm(fabI) embryos
Mitochondrial dysfunction has been shown to lead to embryonic lethality (14) (15) (16) (17) , and mutations in mtFAS of S. cerevisiae have been reported to result in severe respiratory chain (RC) defects (6). We therefore investigated whether Mecr mutations are linked to mitochondrial RC dysfunction. As Mecr tm1d embryos that were available at E 8.5 were too small for this type of analysis and were frequently already dead or dying at E 9.5, we turned to the Mecr tm(fabI) model for which embryos were robustly alive at E 9.5. Mitochondrial respiratory function was analyzed from homogenized embryonic materials with an Oxygraph-2k. Incubation of homogenized, permeabilized embryos in a mitochondrial respiration media supplemented with glutamate, malate, and pyruvate revealed similar basal O 2 consumption rates per embryo with 11.34 6 2.98 pmol/s per embryo, 11.96 6 2.04 pmol/s per embryo, 9.14 6 2.22 pmol/s per embryo for wild type, heterozygous and fabI knock-in, respectively (values in means 6 SD). The rate of oxygen consumption increased to 17.92 6 4.64 pmol/s per embryo, 22.94 6 5.10 pmol/s per embryo after addition of adenosine diphosphate (ADP) in wild type and heterozygous embryos whereas the increase in rate in homozygous fabI knock-in was not statistically significant (Fig. 4C) . All the embryo preparations were unresponsive to the addition of cytochrome c, confirming the integrity of the outer mitochondrial membrane in these preparations. Further addition of succinate, wherefrom electrons are transferred to coenzyme Q bypassing the complex I in the RC, led to a further increase in 5A-D) . Moreover, the organization of trophoblast giant cells, spongiotrophoblasts and the labyrinthine layer of the fetal part of placenta in these specimens was poor and maternal and fetal blood spaces in labyrinth were not evident ( Fig. 5C and D) . Analyses of electron micrographs of placenta from Mecr tm(fabI) embryos further confirmed failure of differentiation of labyrinthine trophoblasts as well as maternal and fetal blood spaces in labyrinth, which were indistinguishable. Furthermore, electron microscopic analyses revealed evenly distributed mitochondria of oval shape in wild type cells with clearly visible and organized cristae (Fig. 5E ). In contrast, mitochondria in labyrinthine trophoblasts of homozygous mutant embryos were clustered, irregular in shape and electron-lucent without clear cristae structure (Fig. 5F ).
Mecr deficiency is associated with disturbed transcriptional control by PPAR in fetal placenta Fig. S6D ).
To obtain further information on effects of Mecr mutations on placental development, we analyzed the population of trophoblast giant cells and spongiotrophoblast cells in fetal placenta associated with wild type and homozygous fabI knock-in embryos. We carried out RNA in situ hybridization using probes specific for trophoblast giant cells (Pl1) as well as spongiotrophoblast cells (Tpbpa or 4311). The cellular linings of both trophoblast cell types were thinner in fetal placenta of homozygous knock-in embryos (Fig. 6A-D) . In addition, folliculotropin (Fol) was also undetectable by immunohistochemical means in fabI knock-in placenta (Fig. 6F) , whereas a strong signal was observed in wild type and heterozygous placenta (Fig. 6E ).
PPARc and PPARb/d mediated signalling are essential for placental development (19, 20) while no placental abnormalities in PPARa knock-outs were reported (21) . Mecr has recently been implicated in PPARa and c mediated signalling (11) . Therefore, we analyzed PPAR target genes expression by RT-PCR using total RNA samples isolated from whole placentas of embryos of Mecr tm(fabI) breedings. The Muc1 transcript was chosen as a representative PPARc target gene (22) , while the Mdfi transcript is a marker specific for PPARb signalling (23) . Both transcripts ( Fig. 6G and H) were found to be reduced to 50% in homozygous mutant placenta compared with WT controls. This result suggests that a negative effect of Mecr on placental development is mediated in part by disturbed PPAR signallings.
Cardiac developmental defects in Mecr tm(fabI)
embryos at E 10.5
The histological analysis of hearts from wild type embryos revealed a clearly distinguishable atrial chamber, ventricular chamber, and endocardial cushion associated with atrioventricular canal at E 10.5 (Fig. 7A) . In homozygous fabI knock-in mutants, hearts were underdeveloped and resembled embryonic heart at E 8.5-9.5. The primitive atrial chamber and ventricular chamber were observed in homozygous mutants (Fig. 7B) . The trabeculation in myocardial wall of ventricular chambers was visible in both wild type and mutant heart (arrows, Fig. 7A and B). The embryos in uterine swelling were taken for micro computed tomography (mCT) imaging. Based on the phenotypes of more than 100 genetically confirmed embryos from Mecr tm(fabI)
breeding at E 10.5, the small and pale uterine swellings were taken to present homozygous fabI knock-in mutants and large and red uterine swellings were chosen as controls (wild type/ heterozygous). The mCT analysis revealed that in mutant embryos heart and cavity volumes were 19 and 21% smaller than in controls, respectively, and the fabI knock-in embryo had a two chambered heart (Fig. 7D) whereas control embryo had three to four chambered heart (Fig. 7C) .
Discussion
Mitochondrial defects are associated with many diseases like obesity, diabetes, cancer, cardiovascular and neurodegenerative disorders, demonstrating the vital role of these organelles in strates. G þ MþP is referring to respiratory rate in incubations using glutamate (G), malate (M) and pyruvate (P) as described in Materials and Methods. Note that basal rates of oxygen consumption were similar in all embryos tested at E 9.5. Relative respiratory rates after addition of ADP (D), cytochrome c (c), succinate (S) and F max after addition of the uncoupler FCCP into the incubations are indicated. The mutant knock-in embryo was unresponsive between titration of each substrate compared with wild type and heterozygous embryos. *P < 0.05, **P < 0.01, ***P < 0.001. cellular function. Functional mitochondria are also essential for embryogenesis (14) (15) (16) (17) . Aiming to understand the physiological role of mtFAS in mammals, we here generated several mutated Mecr mouse lines and analyzed the causes for the ensuing developmental defects. Unlike the mutations that cause MEPAN, which results from compromised function of human MECR (10), our knock-out and fabI knock-in constructs were unable to support development of an organism sufficiently healthy to survive until birth. Although the value of our results is limited in terms of in understanding the progression of MEPAN in patients, which may be more appropriately addressed in neuron-specific Mecr knock-out models, they yielded in some intriguing insights in the role of Mecr and mtFAS in embryonic development.
The surprisingly wide time window of embryonic death of the homozygous Mecr tm1a mouse line embryos, varying from E 9.5 to E 15.5, was indicative of aborted embryonic development due to a variety of etiological factors (18) . The live homozygous Mecr tm1a 'knock-out-first' embryos at E 14.5 had hemorrhages and were paler. Paleness can be attributed to defective erythropoiesis (24) and hemorrhage may be due to failure in either platelet development (25) or angiogenesis (26) . These defects may all contribute to embryonic death at this stage of development. Based on several observations, we propose that homozygous Mecr tm1a embryos still have residual Mecr function. In this (28, 29) . Our investigation of the placental development in our mouse lines confirmed that these organs were hypoplastic and disorganized. The trophoblast cells have many functions in developing placenta, as for example secretion of hormones regulating the growth of fetal and maternal components of this organ (23, (30) (31) (32) . The overall smaller size and the irregular arrangement of the fetal part of the placenta (Fig. 5A-D) can be the result of trophoblast differentiation defects (23, 33) . Our RNA in situ hybridization studies for markers of trophoectoderm (Pl1) and ectoplacental cone descendants (Tpbpa/4311) (23, 34, 35) indicated a highly reduced cell population expressing Pl1 and Tpbpa/4311 in homozygous mutant embryonic placenta ( Fig. 6B and D) . The diminished trophoblast lining is congruent with the thinning of placenta we observed in histological analysis, as is the apparent absence of Fol in trophoblast cells of placenta associated with fabI knock-in embryos. The PPAR signalling pathways play important roles in placental development (23, 29, 33, 36, 37) . The transcriptional control of PPAR regulated genes by Mecr has been reported to be mediated by an mtFAS product (11) or a cytosolic isoform of Mecr (12) . The evidence presented in the latter investigation suggests that the cytosolic Mecr variant arises from a splicing variant of the Mecr transcript that results in translation initiation in exon 2 further downstream of the coding region, producing a Mecr isoform devoid of the mitochondrial targeting signal. The expression of non-mitochondrial variant of Mecr might not be completely abolished by insertion of a transcriptional terminator after exon 1 in our Mecr tm1a model. (23, 36, 38) . In both of these mutants, disturbed trophoblast differentiation was reported as cause of death (23, 33) . Our analysis revealed a reduction of PPARc and b/d target gene expression in placentas of fabI knockin embryos compared with wild type controls. As the RNA samples were isolated from placenta carrying both maternal and fetal contributions, the actual reduction of PPAR target gene expression is likely to be much more severe in the fetal fraction than evident in our data. Although our results present no definite proof of a role of Mecr in the PPAR signalling pathway, they are consistent with the previous reports of a possible regulatory role of Mecr mediated by PPAR pathways (11, 12) . It is therefore not completely ruled out that the possible disrupted PPAR signalling might contribute to placental developmental failure in the mutants. If such a link exists, it is worth of noting that the physiological ligands of PPARs are fatty acids and eicosanoids (39, 40) and PPARs are located in the extramitochondrial space. However, free standing ACP of mtFAS is localized in mitochondria. Therefore, a role for a non-mitochondrial isoform of Mecr protein or unknown downstream events would be more plausible as effector to PPAR signalling than a product of mtFAS.
Another possible cause for embryonic lethality between E 9 and E 12 is a cardiovascular developmental defect (25) . In line with the generalized retarded growth, the heart was found underdeveloped in the homozygous mutants compared with D) mCT analysis of heart. The embryonic heart had three to four chambered appearance in control embryos (C) whereas two chambered in mutant hearts (D). The encircled heart region is shown in insert. The distance between each purple dot is 500 mm.
controls. Further histological analysis of homozygous fabI knock-in embryos at E 10.5 showed delayed cardiac development in comparison to wild type controls (Fig. 7A and B) . The mCT analysis confirmed that heart appeared tubular in homozygous Mecr tm(fabI) mutants, whereas chamber-like organization appeared in wild type controls at E 10.5 ( Fig. 7C and D ). An important finding of our study was the effect of Mecr inactivation on mitochondrial function in embryos and placentas of Mecr tm(fabI) mutants. The results of our electron microscopy studies on placentas of mutant embryos, revealing an abnormal mitochondrial structure in labyrinthine trophoblast, in conjunction with our observation of a reduced rate of mitochondrial respiration in permeabilized cells from fabI knock-in embryos indicate that absence of Mecr or diminished ETR activity yields in respiratory dysfunction also in mammals. This conclusion is in line with data reported for experiment on knocking down ACP in cultured HEK293T cells and in mitochondria isolated from tamoxifen inducible conditional Mcat knock-out mice (7, 41) and congruent with results reported for yeast (6) . Several mouse models deficient in mitochondrial energy metabolism and embryonic development have been described in the literature. For instance, Johnson et al. (42) reported that a knock-out of the Pdha1 subunit of PDH yields in embryos with disrupted mitochondrial energy metabolism and developmental delay at E 9.5 stage followed by subsequent death. This time period is close to the findings reported here, suggesting that oxygen dependent mitochondrial metabolism plays an important role at this stage of development. This is in agreement with Larsson et al. (14) , who reported embryonic death at E 8.5 to E 10.5 with loss of mitochondrial DNA and cytochrome c oxidase activity in mitochondrial transcription factor A knock-out embryos. Another example for mitochondrial dysfunction associated embryonic lethality is embryonic death at mid-gestation caused by cytochrome c deficiency (15) . Although the conceptus is able to oxidize pyruvate during pre-implantation, there are several reports indicating that this stage of development can be successfully completed in spite of a respiratory defect (43) . Energy metabolism of early post-implantation embryos depends on anaerobic glycolysis which is maintained until days E 6 to E 7.5 (44).
Our current work on mtFAS applying three different genetic modifications in Mecr gene showed that disruption of activity of this pathway leads to embryonic lethality due to pleiotropic effects including disturbances in fetal placental and cardiovascular developments and retardation of embryonic growth at the stage when the embryos become depending on aerobic metabolism. These defects coincided with disturbed PPARc and PPARb/ d-mediated signalling. Based on the analysis of several factors involved in mitochondrial function, we propose that diminished mitochondrial respiratory capacity is upstream of this pantropic morphological phenotype. In view of the data presented in this work, mtFAS defects should be considered as yet another potential factor for embryonic loss also in humans. Production of Mecr tm1a and Mecr tm1d mice 'Knock-out-first' type Mecr mutant mice, B6Dnk; B6Brd; B6N-Tyr c-Brd Mecr tm1a(EUCMM)Wtsi (EM: 04825) were derived from cryopreserved heterozygous embryos, obtained from the EMMA as a free of charge Transnational Access service. These animals harbor a construct where an FRT-flanked neo selection cassette, followed by a strong transcriptional terminator signal was placed between exons 1 and 2 of the Mecr gene, with loxP sites introduced 5 0 and 3 0 of exon 2 (Fig. 1A) . The pups born after embryo transfer were back-crossed with C57BL/6JOlaHsd. 
Materials and Methods

Mouse strains
Generation of Mecr tm(fabI) mice
Starting with a commercial knockout cassette (loxP-FRT-PGKgb2-neo-FRT, Gene Bridges, Heidelberg, Germany), a knock-in cassette for insertion of fabI in frame with base pair sequence of 5' region of Mecr exon 2 was constructed. In vitro gene synthesis was used to produce a cassette with a fabI double HA tag replacing the loxP site in this construct, as well as homologous arms (Gene Script USA, Piscataway, NJ). The construct includes a NotI site followed by 26 bp from intron 1 and 54 bp from exon 2 of mouse Mecr, whole fabI with double HA tag, BGH transcription terminator and FRT-flanked neomycin selection cassette having another transcription terminator, and BamHI restriction site (i) and (ii) yield in about 1400 bp product from wild type, and (i) and (iii) about 1600 bp product from fabI inserted DNA. Two ES cell clones were selected for injection into C57BL/6JOlaHsd blastocysts.
The male chimeras harboring a knock-in insert were bred with C57BL/6JOlaHsd females to generate heterozygous mice. The heterozygotes appeared healthy and were interbred to generate homozygous Mecr tm(fabI) mice. A Mecr tm(fabl) mouse line devoid of the selection cassette was also generated by deleting the FRT-flanked selection cassette by breeding with Tg(ACTFLPe)9205Dym/J (45) 
RT-PCR studies
Mitochondrial respiratory complex activity studies
The respiratory complex activity measurements were done by modification of the protocol described previously in (49) . Briefly, the embryos were dissected from pregnant mothers and kept in PBS on ice until the measurements were carried out. Embryo material was gently homogenized in mitochondrial respiration medium MiR05 (0.5 mM EGTA; 3 mM MgCl 2 ; 60 mM lactobionic acid; 20 mM taurine; 10 mM KP i ; 20 mM HEPES; 110 mM D-sucrose; 1 g/l BSA, essentially fatty acid free; pH 7.1) before measurement. The homogenate prepared from each embryo was placed into the Oxygraph-2k chamber (OROBOROS Instruments, Innsbruck, Austria) in a total volume of 2 ml. The chamber was closed and the cells were permeabilized by titration of 5 mg digitonin into the chamber. Glutamate (final concentration of 10 mM), malate (2 mM) and freshly prepared pyruvate (5 mM) were titrated into the chamber and the baseline respiration of the permeabilized cells in the homogenate was measured. Further substrates were titrated in the chamber in the following order: ADP (5 mM), cytochrome c (10 mM), succinate (10 mM) and FCCP (titrated into the incubation mixture in 0.5 mM steps until maximum respiration is reached) as uncoupler. The change of oxygen consumption in the chamber after each titration was recorded.
Embryonic lethality studies
The heterozygous females and males of 'knock-out-first' (Mecr and dissection of pregnant heterozygous females of all lines, at various days of gestation. The morphological appearance and viability of the embryos were assessed. To determine the genotype of embryos, a tail sample or whole embryos (if they were E 8.5 or younger) were collected. Embryos from E 9.5 and older were collected for histological, biochemical and molecular studies. Placenta samples were collected for molecular, ultrastructural and histological analysis.
Histological analysis
Each uterine swelling was separated. The outer layers of the uterus were removed and the embryos were harvested. The rest of myometrium with placenta was fixed in 4% paraformaldehyde in 100 mM NaP i buffer (pH 7.4) over night and the uterus was cut into halves mid-sagittally. One of the half was used for regular histology processing and embedded in paraffin. Sagittal sections of 5 mm were used for haematoxylin and eosin (H&E) staining or immunohistochemistry with Mecr antibody (1:250). Sections of 2.5 mm were used for immunohistochemistry probing for Fol with antibody raised against human chorionic gonadotropin ((1: 4000, Dako, Glostrup, Denmark) and for RNA in situ hybridization respectively. The 5 mm sections from wild type and fabI knock-in embryos at E 10.5 from Mecr tm(fabI) breedings
were also processed similarly to analyze the heart morphology. The stained sections were analyzed with Olympus BX 51 microscope equipped with Cell M imaging software (Olympus, Planegg, Germany).
Transmission electron microscopy
Placenta samples were fixed in a glutaraldehyde (1%), formaldehyde mixture (4%) in 100 mM NaP i . They were post fixed in 1% osmium tetroxide, dehydrated in acetone and embedded in Epon LX 112 (Ladd Research Industries, Williston, VT). Thin sections (70 nm) were cut with Leica Ultracut UCT ultramicrotome, stained with uranyl acetate and lead citrate and examined in Tecnai G2 Spirit 120 kV transmission electron microscope (FEI Europe, Eindhoven, The Netherlands). Images were captured by Quemesa CCD camera operated with iTEM software (Olympus Soft Imaging Solutions, Munster, Germany).
Micro computed tomography
The uterine swelling with embryos at E 10.5 were dissected and prepared for high-resolution mCT imaging. For microstructural imaging samples were paraformaldehyde fixed, dehydrated with graded ethanol series and moved to hexamethyldisilazane (HMDS). HMDS treated uterine swellings were attached with dental wax to holder and placed in mCT scanner (Skyscan 1272, Brü ker microCT, Kontich, Belgium). For imaging low energy Xrays with 40 kV and no filtering was applied. Pixel size was set to 1.75 mm and 1800 projections were collected over 360 . Each projection was collected for 1815 ms and averaged three times. Projection images were reconstructed with NRecon-software (v.1.6.9.8, Brü ker microCT) and ring artefact and beam hardening corrections were applied. 3D data sets were visualized with CTVox (3.2.0 r1294). Heart morphology was analyzed using CTAn software, where heart was first manually segmented by drawing regions of interest (ROIs). ROIs were refined with shrink-wrap function and original image. Chambers were extracted with threshold and morphological operations and 3D model and analyses were performed. This provided measures of heart, heart muscle volume and chambers. Results from analysis were rendered in CTVol software.
RNA in situ hybridization
The 7 mm sagittal sections of myometrium with placentas from E 9.5 embryos were used. Briefly, antisense and sense riboprobes for Pl1 (34, 35) and Tpbpa or 4311 (23), were generated by in vitro transcription of the corresponding cDNA clones with SP6, T7 or T3 RNA polymerase, using DIG RNA labelling mix (Roche).
In situ hybridizations were done following the routine method (50) . After hybridization and post hybridization washing, digoxigenin labelled sections were detected by alkaline phosphatase conjugated antiDIG antibody and Fast red as substrate (Roche). Counterstaining was done with Mayer's hematoxylin and coverslips mounted with ImmuMount (Thermo Scientific). 
Statistical analysis
Supplementary Material
Supplementary Material is available at HMG online.
